ePedigree Maximize
Customers Minimize
 Minimize

Meditor Pharmaceuticals Provides Updates on Phase II Eastern European Clinical Study -
October 4, 2006 read more ...

Meditor Pharmaceuticals Provides Update on Phase II -
 September 27, 2006 read more ...

Meditor Pharmaceuticals Initiates Phase II Trial For Intradialytic Hypotension -
 April 20, 2006 read more ...

  Minimize


To find out about the latest information, activities, bio tech stock prices, analyst information as well as news on the biotechnology sector  - click here.

 

Wednesday, March 10, 2010  
Customers Minimize

CAPABILITIES.gifOur Customers

  • Established small to medium size pharmaceutical companies
  • Emerging pharmaceutical companies
  • Biotech
  • Medical device companies

Our Customer’s Customer

  •  
  • Managed care organizations including HMOs, PBMs & large medical groups
  • Federal and State government agencies including VA, DOD and Medicaid

 

Corporate retail chains, and national drug wholesalers and specialty distributors

 

    • In selected markets managed care controls the demand for pharmaceuticals and selected procedures and protocols

    • Authority has shifted from individual prescribers to formulary and medical committees

    • Managed care is expanding strategic alliances and partnerships centered around specific therapeutic areas:

    • Currently over 80% of all prescriptions are going through a third party payer, while 85% of the drug distribution is controlled by the top 15 corporate chains and drug wholesalers

    • New product success is dependent upon access to the critical managed care markets and key distribution channels
Terms Of Use Privacy Statement
Copyright 2006 - VCG & Associates powered by 4Smartphone